Trial intelligence / Profile preview

Ixabepilone plus Bevacizumab in Metastatic Breast Cancer

NCT00370552Phase 2Completed

Sponsor
R-Pharm
Start
Mar 2007
Primary completion
Nov 2009
Modality
Small Molecules
Countries
5
01

Overview

A Phase 2 trial of ixabepilone in breast cancer, sponsored by R-Pharm. Started Mar 2007; status: completed.

02

Drugs

ixabepilone
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00370552.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00370552.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call